Saturna Capital Corp Has $63.66 Million Position in Agilent Technologies, Inc. $A

Saturna Capital Corp lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 26.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 539,400 shares of the medical research company’s stock after selling 196,344 shares during the period. Saturna Capital Corp owned 0.19% of Agilent Technologies worth $63,655,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Sierra Legacy Group raised its position in shares of Agilent Technologies by 63.2% in the second quarter. Sierra Legacy Group now owns 10,780 shares of the medical research company’s stock valued at $1,272,000 after purchasing an additional 4,175 shares during the period. Empowered Funds LLC boosted its holdings in shares of Agilent Technologies by 11.4% during the second quarter. Empowered Funds LLC now owns 43,678 shares of the medical research company’s stock worth $5,144,000 after acquiring an additional 4,481 shares during the period. Vanguard Group Inc. grew its position in shares of Agilent Technologies by 1.8% in the second quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock valued at $4,012,086,000 after purchasing an additional 589,219 shares during the last quarter. Dorsey & Whitney Trust CO LLC increased its stake in shares of Agilent Technologies by 9.7% during the second quarter. Dorsey & Whitney Trust CO LLC now owns 6,093 shares of the medical research company’s stock worth $719,000 after purchasing an additional 540 shares during the period. Finally, Nomura Asset Management Co. Ltd. lifted its holdings in Agilent Technologies by 4.7% during the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 92,433 shares of the medical research company’s stock worth $10,908,000 after purchasing an additional 4,108 shares during the last quarter. 87.41% of the stock is owned by institutional investors.

Agilent Technologies Price Performance

A stock opened at $143.86 on Wednesday. The company’s 50-day moving average price is $138.31 and its two-hundred day moving average price is $124.52. The firm has a market cap of $40.78 billion, a P/E ratio of 33.77, a P/E/G ratio of 4.67 and a beta of 1.29. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm’s revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter last year, the business posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th were issued a dividend of $0.248 per share. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is 23.24%.

Analysts Set New Price Targets

A number of brokerages have commented on A. Barclays upped their price objective on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a report on Thursday, October 2nd. Robert W. Baird upped their price target on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research note on Thursday, August 28th. Wells Fargo & Company raised their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price objective for the company. Finally, Evercore ISI increased their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $149.62.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 12,490 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the completion of the sale, the chief executive officer directly owned 33,448 shares in the company, valued at $5,017,200. This represents a 27.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.26% of the company’s stock.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.